Exploring Serum Lipid Profile in Patients Diagnosed with Myocardial Infarction at Hayat Abad Medical Complex Peshawar

Authors

  • Mubassir Ur Rehman Department of Allied Health Sciences, NCS University System, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan
  • Murtaza khan Department of Allied Health Sciences, NCS University System, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan
  • Muhammad Asim Department of Allied Health Sciences, NCS University System, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan
  • Asad Jamal Department of Allied Health Sciences, NCS University System, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan
  • Zahid Ur Rahman Department of Allied Health Sciences, NCS University System, Peshawar 25000, Khyber Pakhtunkhwa, Pakistan

DOI:

https://doi.org/10.31580/868q6533

Keywords:

Blood Biomarkers, Lipid profile, Myocardial Infarction.

Abstract

Myocardial Infarction (MI) is a critical medical emergency requiring prompt diagnosis to ensure effective management and prevent life-threatening complications. Blood biomarkers play a vital role in predicting and mitigating the risk of MI. This study was conducted in the cardiology department of Hayatabad Medical Complex, Peshawar, to evaluate serum lipid profiles in MI patients. A total of 109 diagnosed MI patients were recruited through a non-probability convenient sampling method. Aseptic collection of 3–5 mL blood samples was performed, and the samples were processed at the tertiary healthcare facility. Serum was separated by centrifugation at 1000 revolutions per minute (RPM) for one minute. Lipid levels, including total cholesterol, triglycerides, high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL-C), and very low-density lipoprotein cholesterol (VLDL-C), were measured using a COBAS analyzer. Statistical analysis revealed a predominance of male patients (63.3%) compared to females (36.7%), with the majority of cases observed in the age group of 51–60 years (29%). Dyslipidemia was a prominent finding, with elevated VLDL-C levels noted in 57.8% of patients, hypertriglyceridemia in 33.9%, and significantly reduced HDL levels in 46.8%. Additionally, 11.9% of patients exhibited elevated LDL cholesterol, while hypercholesterolemia was observed in 2.8% of cases. These findings underscore the significant role of dyslipidemia in predisposing individuals to MI. Early detection and management of lipid abnormalities are essential to prevent the progression to myocardial infarction and reduce associated morbidity and mortality.

References

Khan HA, Alhomida AS, Sobki SH: Lipid profile of patients with acutemyocardial infarction and its correlation with systemic inflammation.Biomarker insights. 2013;8:BMI. S11015.

Anderson JL, Morrow DA: Acute myocardial infarction. New England Journalof Medicine. 2017;376(21):2053-64.

Thygesen K, Alpert JS, White HD, Task Force Members: Chairpersons: Kristian Thygesen JSA, Harvey D. White *, Biomarker Group: Allan S. JaffeC, Fred S. Apple , Marcello Galvani , Hugo A. Katus , L. Kristin Newby , JanRavkilde, ECG Group: Bernard Chaitman C-o, Peter M. Clemmensen , MikaelDellborg , HanochHod , PekkaPorela. Universal definition ofmyocardial infarction. circulation. 2007;116(22):2634-53

Lu L, Liu M, Sun R, Zheng Y, Zhang P. Myocardial infarction: symptoms andtreatments. Cell biochemistry and biophysics. 2015;72:865-7.

Ference BA, Graham I, Tokgozoglu L, Catapano AL. Impact of lipids oncardiovascular health: JACC health promotion series. Journal of the AmericanCollege of Cardiology. 2018;72(10):1141-56.

Frangogiannis NG. Pathophysiology of myocardial infarction. ComprehensivePhysiology. 2011;5(4):1841-75.

Kumar N, Kumar S, Kumar A, Shakoor T, Rizwan A. Lipid profile of patientswith acute myocardial infarction (AMI). Cureus. 2019;11(3).

Zafar A, Shahnawaz S, Malik SA, Javed MS, Naeem N, Ali S, Hussain G, Tanveer K, Sheikh IS, Iqbal K, Dogar MZ. A Comparative Study on the Dysregulated levels of Serum Ascorbic Acid, Glycated Hemoglobin and Lipids Profile in Type-2 Diabetics. Pak-Euro Journal of Medical and Life Sciences. 2021;4(3):161-70.

Albrektsen G, Heuch I, Løchen M-L, Thelle DS, Wilsgaard T, Njølstad I,Bønaa KH. Lifelong gender gap in risk of incident myocardial infarction: theTromsø study. JAMA internal medicine. 2016;176(11):1673-9.

Shrivastava AK, Singh HV, Raizada A, Singh SK. Serial measurement of lipidprofile and inflammatory markers in patients with acute myocardial infarction.EXCLI journal. 2015;14:517.

Kim MK, Han K, Kim H-S, Park Y-M, Kwon H-S, Yoon K-H, Lee S-H.Cholesterol variability and the risk of mortality, myocardial infarction, andstroke: a nationwide population-based study. European heart journal.2017;38(48):3560-6.

Nigam P, Narain V, Hasan M. Serum lipid profile in patients with acutemyocardial infarction. Indian journal of clinical biochemistry. 2004;19:67-70.13. Ebrahim S, Sung J, Song Y-M, Ferrer RL, Lawlor DA, Smith GD. Serumcholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction:Korean national health system prospective cohort study. Bmj.2006;333(7557):22.

Ebrahim S, Sung J, Song Y-M, Ferrer RL, Lawlor DA, Smith GD. Serumcholesterol, haemorrhagic stroke, ischaemic stroke, and myocardial infarction:Korean national health system prospective cohort study. Bmj.2006;333(7557):22.

Hadi A, Ilyas M, Ali Z, Farooq F. Age and Gender wise Comparison of Risk Factors in Patients with Acute Myocardial Infarction. Journal of Saidu Medical College, Swat. 2019;9(1).

Channamma G. Age and Gender distribution in patients with acute Myocardial Infarction. Medica Innovatica (Original article). 2016;5:29-31.

Published

2024-09-30

Issue

Section

Research Article